Skip to main content
GPLB
OTC Life Sciences

Shell Company Reports Continued Going Concern Doubt, Zero Operations, and Related Party Dependence

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$0.017
Mkt Cap
$342.11K
52W Low
$0
52W High
$2.6
52W Position
Off High info
99% below high
Rel. Volume info
3.4× avg
Market data snapshot near publication time

GPLB filed a Legal and Risk Events on elevated volume (3.4× avg).

Summary

Green Planet Bio Engineering's Q1 2026 report reiterates its status as a non-operating shell with a going concern warning, zero cash, and complete reliance on related party funding.


Key Events · Legal and Risk Events · GPLB

  • Going Concern Warning Reiterated

    The company explicitly states substantial doubt about its ability to continue as a going concern for the next twelve months, dependent on continued support from a related party.

  • Non-Operating Shell Status Confirmed

    Green Planet Bio Engineering remains a public reorganized shell corporation with no active business operations and no revenue for the quarter ended March 31, 2026.

  • Zero Cash and Significant Deficit

    The company reported $0 cash and a working capital deficit of $511,920 as of March 31, 2026, alongside an accumulated deficit of $1,141,540.

  • Complete Reliance on Related Party Funding

    All operating expenses are financed by a related party of the majority stockholder, which advanced an additional $3,850 after the quarter end.


Analysis · GPLB · Life Sciences

This quarterly report confirms Green Planet Bio Engineering remains a non-operating shell company with no revenue and zero cash. The company explicitly states substantial doubt about its ability to continue as a going concern, relying entirely on a related party for all funding. The working capital deficit of $511,920 significantly exceeds the company's market capitalization, highlighting severe financial distress and an unsustainable operational model.

At the time of this filing, GPLB was trading at $0.02 on OTC in the Life Sciences sector, with a market capitalization of approximately $342.1K. The 52-week trading range was $0.00 to $2.60. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GPLB - Latest Insights

GPLB
May 15, 2026, 12:19 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0171
Real-time Price: $0.013 info
Change: -$0.0041 (-24%) info
Market Cap: $260.083K info
GPLB
Mar 31, 2026, 4:10 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.0171
Real-time Price: $0.013 info
Change: -$0.0041 (-24%) info
Market Cap: $260.083K info